Your browser doesn't support javascript.
loading
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.
Goodman, Shaun G; Steg, Philippe Gabriel; Szarek, Michael; Bhatt, Deepak L; Bittner, Vera A; Diaz, Rafael; Harrington, Robert A; Jukema, J Wouter; White, Harvey D; Zeiher, Andreas M; Manvelian, Garen; Pordy, Robert; Poulouin, Yann; Stipek, Wanda; Garon, Genevieve; Schwartz, Gregory G.
Affiliation
  • Goodman SG; Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada.
  • Steg PG; St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Szarek M; Université Paris-Cité, Institut Universitaire de France, Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, FACT (French Alliance for Cardiovascular Trials), and INSERM U1148, F-75018 Paris, France.
  • Bhatt DL; CPC Clinical Research and Division of Cardiology, University of Colorado School of Medicine, Aurora, 80045 CO, USA.
  • Bittner VA; State University of New York, Downstate Health Sciences University, Brooklyn, NY 11203, USA.
  • Diaz R; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Harrington RA; Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
  • Jukema JW; Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, S2000 Rosario, Argentina.
  • White HD; Cornell University, New York, NY 10065, USA.
  • Zeiher AM; Department of Cardiology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Manvelian G; Netherlands Heart Institute, 3511 EP Utrecht, The Netherlands.
  • Pordy R; Green Lane Cardiovascular Research Unit, Te Whatu Ora-Health New Zealand, Te Toka Tumai, and University of Auckland, Auckland 1030, New Zealand.
  • Poulouin Y; Department of Medicine III, Goethe University, 60596 Frankfurt am Main, Germany.
  • Stipek W; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA.
  • Garon G; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA.
  • Schwartz GG; IT&M Stats, Neuilly-sur-Seine 92200, France.
Eur Heart J Cardiovasc Pharmacother ; 10(4): 342-352, 2024 Jul 16.
Article in En | MEDLINE | ID: mdl-38658193
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / PCSK9 Inhibitors / Cholesterol, LDL Limits: Humans Language: En Journal: Eur Heart J Cardiovasc Pharmacother Year: 2024 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / PCSK9 Inhibitors / Cholesterol, LDL Limits: Humans Language: En Journal: Eur Heart J Cardiovasc Pharmacother Year: 2024 Document type: Article Affiliation country: Country of publication: